Join the Acetaminophen group to help and get support from people like you.
Acetaminophen News (Page 2)
FDA Medwatch Alert: Acetaminophen Tablets by Medline Industries: Recall - Mislabeling with Incorrect Strength
ISSUE: On October 9, 2015, Medline Industries, Inc. announced that it will initiate a voluntary nationwide recall of lot # 45810 of Acetaminophen tablets, 500mg, uncoated compressed tablets to the...
FDA Medwatch Alert: Prescription and Over-the-Counter (OTC) Pain Medicines: Drug Safety Communication - FDA Review of Possible Risks of Pain Medicine Use During Pregnancy
[Posted 01/09/2015] ISSUE: FDA is aware of and understands the concerns arising from recent reports questioning the safety of prescription and over-the-counter (OTC) pain medicines when used ...
FDA Medwatch Alert: Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to Discontinue Prescribing and Dispensing
ISSUE: FDA is recommending health care professionals discontinue prescribing and dispensing prescription combination drug products that contain more than 325 milligrams (mg) of acetaminophen per...
FDA Medwatch Alert: Perrigo Acetaminophen Infant Suspension Liquid: Recall - Potential Defect with Co-packaged Oral Syringe
ISSUE: The Perrigo Company announced that it has initiated a voluntary, nationwide product recall to the retail level of 18 batches of its acetaminophen infant suspension liquid, 160 mg/5 mL, sold in...
FDA Medwatch Alert: Acetaminophen: Drug Safety Communication - Association with Risk of Serious Skin Reactions
ISSUE: FDA notified healthcare professionals and patients that acetaminophen has been associated with a risk of rare but serious skin reactions. Acetaminophen is a common active ingredient to treat...
FDA Medwatch Alert: Infants' Tylenol Oral Suspension, 1 oz. Grape: Recall - Dosing System Complaints
ISSUE: McNeil Consumer Healthcare notified the public of a recall of seven lots (approximately 574,000 bottles) of Infants’ TYLENOL Oral Suspension, 1 oz. Grape. There were complaints from consumers w...
FDA Medwatch Alert: Liquid Acetaminophen marketed for infants: Drug Safety Communication - Potential for Dosing Errors
[Posted 12/22/2011] ISSUE: The FDA is informing the public that an additional concentration of liquid acetaminophen marketed for “infants” (160 mg/5 mL) is now available. This change in the conc...
FDA Medwatch Alert: Tylenol Extra Strength Caplets, 225 count bottles: Recall - Uncharacteristic Odor
ISSUE: McNeil Consumer Healthcare is recalling one product lot of Tylenol Extra Strength Caplets, 225 count bottles, distributed in the U.S. The recall stems from a small number of odor reports,...
Cadence Pharmaceuticals Announces FDA Approval of Ofirmev (acetaminophen) injection for the Management of Pain and Fever
SAN DIEGO, Nov. 2, 2010 /PRNewswire-FirstCall/ – Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Ofirmev...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Sciatica, Muscle Pain, Back Pain, Chronic Pain, Pain, Fever, Headache, Eustachian Tube Dysfunction, Neck Pain, Plantar Fasciitis, Transverse Myelitis
Related drug support groups
Tylenol, Paracetamol Teva, Paracetamol